Real-life appraisal on blood pressure targets achievement in adult outpatients at high cardiovascular risk

被引:1
|
作者
Presta, Vivianne [1 ]
Citoni, Barbara [1 ]
Figliuzzi, Ilaria [1 ]
Marchitti, Simona [2 ]
Ferrucci, Andrea [1 ]
Volpe, Massimo [1 ,2 ]
Tocci, Giuliano [1 ,2 ]
机构
[1] Univ Rome Sapienza, St Andrea Hosp, Fac Med & Psychol, Dept Clin & Mol Med,Div Cardiol, Rome, Italy
[2] IRCCS Neuromed, Pozzilli, IS, Italy
关键词
Blood pressure control; Hypertension; High cardiovascular risk; Antihypertensive therapy; Primary prevention; Secondary prevention; ESC score; ASSOCIATION STROKE COUNCIL; ADDRESS DOCUMENT 2012; ITALIAN SOCIETY; HYPERTENSIVE PATIENTS; OUTCOMES; DISEASE; DEFINITION; AMLODIPINE; PREVENTION; GUIDELINES;
D O I
10.1016/j.numecd.2020.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Although hypertension guidelines highlight the benefits of achieving the recommended blood pressure (BP) targets, hypertension control rate is still insufficient, mostly in high or very high cardiovascular (CV) risk patients. Thus, we aimed to estimate BP control in a cohort of patients at high CV risk in both primary and secondary prevention. Methods and results: A single-center, cross-sectional study was conducted by extracting data from a medical database of adult outpatients aged 40-75 years, who were referred to our Hypertension Unit, Rome (IT), for hypertension assessment. Office BP treatment targets were defined according to 2018 ESC/ESH guidelines as: a)<130/80 mmHg in individuals aged 40-65 years; b)<140/80 mmHg in subjects aged >65 years. Primary prevention patients with SCORE <5% were considered to be at low-intermediate risk, whilst individuals with SCORE >= 5% or patients with comorbidities were defined to be at very high risk. Among 6354 patients (47.2% female, age 58.4 +/- 9.6 years), 4164 (65.5%) were in primary prevention with low-intermediate CV risk, 1831 (28.8%) in primary prevention with high-very high CV risk and 359 (5.6%) in secondary prevention. In treated hypertensive outpatients, uncontrolled hypertension rate was significantly higher in high risk primary prevention than in low risk primary prevention and secondary prevention patients (18.4% vs 24.4% vs. 12.5%, respectively; P < 0.001). In high risk primary prevention diabetic patients only 10% achieved the recommended BP targets. Conclusions: Our data confirmed unsatisfactory BP control among high-risk patients, both in primary and secondary prevention, and suggest the need for a more stringent BP control policies in these patients. (C) 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:472 / 480
页数:9
相关论文
共 50 条
  • [31] Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting
    André Pacheco Silva
    Jaqueline Scholz
    Tania Ogawa Abe
    Gabriela Gouveia Pinheiro
    Patricia Viviane Gaya
    Alexandre Costa Pereira
    Paulo Caleb Junior Lima Santos
    BMC Cardiovascular Disorders, 16
  • [32] Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs
    Portela-Romero, M.
    Cinza-Sanjurjo, S.
    Conde-Sabaris, P.
    Rodriguez-Manero, M.
    Mazon-Ramos, P.
    Rey-Aldana, D.
    Gonzalez-Juanatey, J. R.
    REVISTA CLINICA ESPANOLA, 2022, 222 (03): : 131 - 137
  • [33] Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk
    Bergmark, Brian A.
    Scirica, Benjamin M.
    Steg, Ph. Gabriel
    Fanola, Christina L.
    Gurmu, Yared
    Mosenzon, Ofri
    Cahn, Avivit
    Raz, Itamar
    Bhatt, Deepak L.
    EUROPEAN HEART JOURNAL, 2018, 39 (24) : 2255 - 2262
  • [34] Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study
    Veerabhadrappa, Praveen
    Diaz, Keith M.
    Feairheller, Deborah L.
    Sturgeon, Kathleen M.
    Williamson, Sheara
    Crabbe, Deborah L.
    Kashem, Abul
    Ahrensfield, Debra
    Brown, Michael D.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2010, 4 (04) : 187 - 195
  • [35] Significance of the second peak of systolic blood pressure for identifying both high and low cardiovascular risk states
    Matsumoto, Chisa
    Tomiyama, Hirofumi
    Yamazaki, Mutsuo
    Sagawa, Yasuhiro
    Teraoka, Kunihiko
    Shirota, Tsunemichi
    Miyawaki, Yoshinori
    Yamashina, Akira
    HYPERTENSION RESEARCH, 2010, 33 (04) : 360 - 366
  • [36] Future Risk of Cardiovascular Disease in Adults with Prolonged Exposure to High Blood Pressure
    Navar-Boggan, Ann M.
    Peterson, Eric D.
    D'Agostino, Ralph B.
    Neely, Benjamin
    Sniderman, Allan D.
    Pencina, Michael J.
    CIRCULATION, 2014, 130
  • [37] Acute effects of waterpipe smoking on blood pressure and heart rate: a real-life trial
    Azar, Rabih R.
    Frangieh, Antonio H.
    Mroue, Jad
    Bassila, Lilliane
    Kasty, Mohamad
    Hage, Georges
    Kadri, Zena
    INHALATION TOXICOLOGY, 2016, 28 (08) : 339 - 342
  • [38] Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients
    Kratz, Mario T.
    Schumacher, Helmut
    Sliwa, Karen
    Schmieder, Roland
    Poess, Janine
    Mahfoud, Felix
    Unger, Thomas
    Lonn, Eva
    Koon, Teo
    Mancia, Guiseppe
    Sleight, Peter
    Yusuf, Salim
    Boehm, Michael
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (03) : 272 - 280
  • [39] High Blood Pressure Variability is an Additional Cardiovascular Risk Factor
    Rodionov, Anton, V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (01) : 94 - 98
  • [40] High-Normal Blood Pressure and the Risk of Cardiovascular Disease
    Kokubo, Yoshihiro
    Kamide, Kei
    CIRCULATION JOURNAL, 2009, 73 (08) : 1381 - 1385